These data suggest that Xbp1 deletion lowers islet insulin content, impairs proinsulin processing and disrupts the capacity of beta cells for insulin secretory adaptation in response to high-fat feeding, ultimately resulting in diabetes. This evidence concerns the gene INS and diabetes mellitus.